Journals / Meme Sağlığı Dergisi / 2012 / Cilt: 8 - Sayı: 1

Turkish radiologic society breast imaging group standarts for breast cancer screening

Türk radyoloji derneği meme radyolojisi çalışma grubu meme kanseri radyolojik tarama standartları

Pages
3–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This guide was created on behalf of the Turkish Society of Radiology Breast Radiology Group, and recommendations for screening of healthy women and women at risk for breast cancer were established in the light of scientific data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is common in Turkey and the most common cause of death from cancer in women.
📊
Key Findings & Data:The first trials about mamographic screening were started in 1960's in the Western countries.
💡
Conclusion & Impact:This guide was created on behalf of the Turkish Society of Radiology Breast Radiology Group, and recommendations for screening of healthy women and women at risk for breast cancer were established in the light of scientific data.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Breast cancer is common in Turkey and the most common cause of death from cancer in women. There is not a written guide in Turkey for breast cancer screening. The first trials about mamographic screening were started in 1960's in the Western countries. The results of 8 randomised controlled trials and screening programs in these countries showed that early detection of breast cancer has reduced breast cancer mortality. The information from these experiences and knowledge in the literature show that annual mammography screening in women over the age of 40 is the most effective method. However, in national screening programs, the aim to ensure optimal benefit in respect of the resources of the country, may cause the need for different screening policies which may not correspond exactly with this guide. This guide was created on behalf of the Turkish Society of Radiology Breast Radiology Group, and recommendations for screening of healthy women and women at risk for breast cancer were established in the light of scientific data.

Özet

Meme kanseri sık görülen ve ülkemizde kadınlarda en sık ölüme neden olan kanserdir. Meme kanseri taraması için Türkiye'de oluşturulmuş bir rehber yoktur. Batı ülkelerinde 1960 yılların sonlarına doğru başlayan mamografi tarama çalışmaları ile meme kanseri erken tanısı için randomize kontrollü 8 çalışma yapılmış ve bu çalışmalarda ve daha sonra uygulamaya geçilen tarama programlarında mamografi taramanın meme kanserinden ölümleri düşürdüğü gözlenmiştir. Literatürdeki bilgiler ve batı ülkelerindeki uygulamalar değerlendirildiğinde 40 yaş üstü kadınlarda yıllık mamografi taraması en etkin yöntem olarak görülmektedir. Ancak ulusal tarama programları o ülkenin kaynakları doğrultusunda ve optimum yararın sağlanması için planlanmış programlar olup bu rehber ile birebir örtüşmeyebilir. Bu rehber Türk Radyoloji Derneği Meme Radyolojisi Grubu adına oluşturulmuştur ve bilimsel veriler ön planda tutularak sağlıklı kadınlarda ve riskli kadınlarda me me kanseri taraması için gerekli öneriler verilmiştir.

🔖

Cite This Article

ARIBAL, E., TUNÇBİLEK, N., ÇELİK, L. (2012). Turkish radiologic society breast imaging group standarts for breast cancer screening. Meme Sağlığı Dergisi, Cilt: 8 - Sayı: 1, 3–10. https://ajindex.com/articles/278328

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer. The Health Insurance Plan Project and its sequelae, 1963-1986. Baltimore: Johns Hopkins University Press, 1988:59–83
  2. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353:1903-8. (PMID: 10371567
  3. Fagerberg G. Experience from randomized controlled breast screening with mammography in Ostergötland county, Sweden: a preliminary report. Recent Results Cancer Res. 1984;90:117. (PMID: 6366951
  4. Bjurstam N, Björneld L, Warwick J, Sala E, Duffy SW, Nyström L, Walker N, Cahlin E, Eriksson O, Hafström LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Säve-Söderbergh J, Wahlin T. The Gothenburg Breast Cancer Screening Trial. Cancer. 2003;97:2387-96. (PMID: 12733136
  5. Frisell J, Glas U, Hellström L, Somell A. Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat. 1986;8:45-54. (PMID: 3790749
  6. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. breast cancer detection and death rates among women aged 40 to 49 years. CMAJ. 1992;147:1459–1476. (PMID:1423087
  7. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study 2: 13–year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92:1490–1499. (PMID:10995804
  8. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973–978. (PMID: 8096941
  9. ACR practice guideline for the performance of screening and diagnostic mammography. ACR PRACTICE GUIDELINE, 2008 10) NCCN National Comprehensive Cancer Network: Breast cancer screening and diagnosis guidelines USA: NCCN Clinical Practice Guidelines in Oncology; 2007
  10. National Comprehensive Cancer Network. National clinical practice guidelines in oncology: breast cancer screening and diagnosis. Version 1.2008. Published April 15, 2008
  11. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-7. (PMID: 12727393) 13)